Lanean...
Molecular features and vulnerabilities of recurrent chordomas
BACKGROUND: Tumor recurrence is one of the major challenges in clinical management of chordoma. Despite R0-resection, approximately 50% of chordomas recur within ten years after initial surgery. The underlying molecular processes are poorly understood resulting in the lack of associated therapeutic...
Gorde:
| Argitaratua izan da: | J Exp Clin Cancer Res |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8325178/ https://ncbi.nlm.nih.gov/pubmed/34330313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-021-02037-y |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|